Alkermes Plc (ALKS)
37.84
+0.49
(+1.31%)
USD |
NASDAQ |
May 27, 15:01
Alkermes Cash from Investing (Quarterly) : -2.077B for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp. Plc | -8.284M |
| Xenon Pharmaceuticals, Inc. | -407.28M |
| Tyra Biosciences, Inc. | -120.24M |
| Spyre Therapeutics, Inc. | 56.58M |
| Agios Pharmaceuticals, Inc. | 141.31M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -165.74M |
| Cash from Financing (Quarterly) | 1.475B |
| Free Cash Flow | 221.80M |
| Free Cash Flow Per Share (Quarterly) | -1.022 |
| Free Cash Flow to Equity (Quarterly) | -1.681B |
| Free Cash Flow to Firm (Quarterly) | -147.40M |
| Free Cash Flow Yield | 3.49% |